Patent · US Active

Benzyl substituted indazoles as BUB1 inhibitors

US10350206B2 · kind B2 · utility

1Cited by

7References

28Claims

0Family size

Assignee

Bayer Pharma Aktiengesellschaft · DE

Inventors

Anne Mengel · Berlin, DE
Hans-Georg Lerchen · Leverkusen, DE
Manfred Möwes · Berlin, DE
Thomas Müller · Bonn, DE
Lars Bärfacker · Oberhausen, DE
Marion Hitchcock · Berlin, DE
Arwed Cleve · Berlin, DE
Joachim Kuhnke · Leverkusen, DE
Hans Briem · Bremen, DE
Gerhard Siemeister · Berlin, DE
Wilhelm Bone · Berlin, DE
Amaury Ernesto Fernandez-Montalvan · Leverkusen, DE
Jens SCHRÖDER · Jena, DE
Ursula Mönning · Mölln, DE
Simon Holton · Berlin, DE

Key dates

Filing date	Sep 17, 2015
Grant date	Jul 16, 2019
Priority date	—
Expiry date	Sep 17, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D403/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of formula (I) as defined herein and their use as pharmaceuticals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.